Ospedale S. Eugenio

Rome 00144

1 studies enrolling now · 3 studies all time

What they study most

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Essential Thrombocythemia, Myelodysplastic Syndromes, Secondary Acute Myeloid Leukemia (Secondary AML, sAML)

Studies at this site

• A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia — Recruiting now
• Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AML — Completed
• Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study — Status unconfirmed